preeclampsia: what we know and what we do not know

Download Preeclampsia: What we know and what we do not know

Post on 15-Sep-2016




0 download

Embed Size (px)


  • Preeelampsia: What We Know and What We Do Not Know

    James M. Roberts

    Preeclampsia remains a major health problem for mothers and infants. Studying the entire patho- physiology of preeclampsia rather than "pregnancy-induced hypertension" has greatly expanded our knowledge of the disorder. Current thinking approaches preeclampsia as a 2 stage disorder: reduced placental perfusion usually secondary to abnormal implantation and a consequent maternal disorder characterized by endothelial dysfunction and subsequent pathophysiological changes. We know much about the 2 stages and less about their linkage. It is evident that reduced placental perfusion is not sufficient to account for the pathophysiology. Reduced perfusion and abnormal implantation occur in other conditions (intrauterine growth restriction and preterm labor) without the maternal syn- drome. This leads to the hypothesis that reduced placental perfusion must interact with maternal constitutional factors to generate the systemic pathophysiology of preeclampsia. The similarities of these risk factors and metabolic alterations between preeclampsia and atherosclerosis suggest a common pathophysiology. Oxidative stress is postulated as the genesis of endothelial dysfunction in atherosclerosis. The author proposes that oxidative stress secondary to reduced placental perfusion leads to endothelial dysfunction, linking the 2 stages of the syndrome. Copyright 9 2000 by W.B. Saunders Company

    E clampsia was first described 2,000 years ago as seizures associated with pregnancy

    and resolving with delivery. 1 It was not until the end of the 19th century that the associa- tion with proteinuria and increased blood pressure ted to the conclusion that this preg- nancy abnormality was more than a seizure disorder. Rather, the occurrence of new onset increased blood pressure, especially in associ- ation with proteinuria, identified a clinical state in which the maternal condit ion could rapidly deteriorate and in which the fetus was at increased risk independent of seizures. Since that time, the 2 markers have been used in several classification schemes to define this syndrome. There are several variations cur- rently in use likely reflecting the fact that the findings by which the syndrome is defined were selected for historical reasons rather

    From the Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pitts- burgh, Pittsburgh, PA. Supported by National Institutes of Health (NIH) Grant: PO1 HD 30367. Address reprint requests to James M. Roberts, MD, Director, Magee- Womens Research Institute, 204 Craft Ave, Suite 610, Pittsburgh, PA 15213; e-mail: Copyright 9 2000 by W.B. Saunders Company O146-0005/00/2401-0007510. 00/0

    than because of a close association with patho- physiology or adverse outcome. It is abun- dantly clear that preeclampsia is not simply pregnancy-induced hypertension and protein- uria. 2 Appreciation of this fact has led to an enormous increase in our understanding of the disorder in the last 15 years. There are many things we now understand about the disorder but likewise many we do not.

    Preeclampsia: What We Know


    Preeclampsia is a leading cause of maternal mor- tality and increases perinatal mortality 5-fold. The increase in perinatal mortality is due, at least, in part to a management strategy which is now, as it was 100 years ago, delivery to termi- nate the pregnancy specific disease. While deliv- ery is always beneficial to the mother, it may result in the transition of a sick fetus in utero to a sick premature neonate in the nursery. Nearly 15% of preterm births are indicated preterm births for preeclampsia. Advances in therapy must target both maternal and neonatal well being.

    24 Seminars in Perinatology, Vol 24, No 1 (February), 2000: pp 24-28

  • Preeclampsia 2 5

    Pathology and Pathophysiology

    The pathological changes of preeclampsia are most consistent with reduced perfusion rather than mechanical disruption of blood vessels. 3 In the liver, for example, the characteristic hemor- rhage and necrosis are most consistent with pro- found vasoconstriction leading to infarction with bleeding into the necrotic area. In addition, subendocardial necrosis, a characteristic change in hypovolemic shock, is also present in women dying with eclampsia. These pathological evi- dences of reduced organ blood flow are sup- ported by the pathophysiological findings of re- duced perfusion to virtually any organ in the preeclamptic woman. 3

    Certain pathological and pathophysiological changes are especially revealing. The kidney of the woman with preeclampsia manifests a char- acteristic morphological change present in no other form of hypertension. This change, termed glomerular endotheliosis, consists of oc- clusion of the glomerular capillary lumen by swollen endothelial and mesangial cells with in- clusions in the basement membrane. Interest- ingly, despite the proteinuria, the renal podo- cytes are completely normal. ~ In addition to showing that preeclampsia is not merely a vari- ant of essential hypertension, the profound changes in the glomerular endothelial cells sug- gest that vascular endothelium may be an impor- tant target in this disorder. Another finding pro- viding special insight is the abnormality of the spiral arteries that perfuse the intervillous space. Ordinarily these vessels undergo striking modi- fication in pregnancy. 4 Their diameter increases dramatically and the smooth muscle and inner elastic lamina of the vessel wall are lost. Endo- thelium no longer lines these cells but rather trophoblast cells that express endothelial anti- gens. 5 These changes do not take place in the vessels that supply the placenta of the pre- eclamptic woman. 6 They may occur in some su- perficial decidual vessels but never extend to the inner third of the myometrium as is characteris- tic of normal pregnancy. These findings illus- trate 2 important points. The first is that a char- acteristic finding in preeclampsia and one which is likely pathophysiologically important, is re- duced placental perfusion. Second, the physio- logical modification that occurs, at least, in part secondary to trophoblastic invasion, is ordinarily

    completed by 20 to 22 weeks gestation. Thus, although preeclampsia characteristically pre- sents in late gestation, the root causes are present much earlier.

    The pathophysiological changes of pre- eclampsia further support the presence of the disorder from earlier gestation than its clinical presentation. 3 The reduced organ perfusion of preeclampsia is secondary to profound vasocon- striction. Rather than an increase in either usual or unique pressors, vasoconstriction is secondary to an increased sensitivity to all pressors. Quite importantly this can be shown in groups of women destined to develop preeclampsia weeks to months before clinically evident disease. Ac- tivation of the coagulation cascade, especially platelets, likely further reduces organ perfusion by the formation of microthrombi. As with vas- cular sensitivity, increased platelet turnover is present months before clinical preeclampsia. Fi- nally, fluid is lost from the vascular compart- ment secondary to vasoconstriction and and to an endothelial leak. These changes further re- duce organ perfusion. Again the consequent re- duction in plasma volume antedates the diagnos- tic findings of preeclampsia. ~

    Endothelial Dysfunction in Preeelampsia

    Normal endothelium buffers response to circu- lating pressors, prevents activation of platelets, activates circulating anticoagulants, and main- tains fluids in the intravascular compartment. 7 Thus, the earliest pathophysiological changes of preeclampsia are all consistent with abnormali- ties of endothelial function. This is further sup- ported hy the morphological changes in the glo- merular capillary endothelium. In addition, biochemical markers of endothelial activation, increased cellular fibronecton, von Willebrand Factor, vascular cell adhesion molecule, and thrombomodulin amongst others, are increased in the circulation of women with preeclampsia. Many of these markers, as well as other indica- tors of endothelial dysfunction, are present weeks to months prior to clinical preeclampsia. Endothelial dysfunction is posited to be a central feature leading to the other pathophysiological changes of preeclampsia explaining the multior- gan involvement and protean manifestations.

  • 26 James M. Robe~r

    The Stages of Preeclampsia

    Preeclampsia is a 2 stage disorder, s Preeclampsia is a pregnancy specific disease that begins to abate with delivery of the placenta. Sixty years ago Page 9 proposed that the placenta was tile important pregnancy component and that the feature that resulted in preeclampsia was re- duced placental perfusion. The abnormal im- plantation, typical of preeclampsia, the associa- tion of preeclampsia with medical disorders characterized by microvascular disease and with obstetrical conditions with large placentas sup- ported this hypothesis. Subsequently, further support was provided by direct measurements of intervillous blood flow and animal experiments. The reduced pertiasion of the intervillous space is the first stage that culminates in stage 2: en- dothelial dysfunction and systemic maternal dis- ease.

    Preeclampsia: What We Do Not Know

    What is the l inkage between the 2 stages of preeclampsia: maternal feta l /p lacental inter- actions. As we begin to explore the l inkage between reduced placental perfusion and the maternal systemic manifestations of pre- eclampsia, it is evident that a l though reduced perfusion seems necessary for preeclampsia it is clearly not sufficient. Not all mothers with growth restricted infants have preeclampsia. S